Creative Bio has launched a portfolio of cell culture tools that it hopes will be useful during the COVID-19 pandemic.
AvantGen has licensed a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development.
ImmunityBio has signed an exclusive worldwide licensing agreement for IosBio's OraPro vaccine platform technology that is currently being investigated in trials of ImmunityBio's second-generation human adenovirus 5 (hAd5) COVID-19 vaccine candidate.
The first patient has been dosed in a phase I clinical trial being conducted by Codagenix and the Serum Institute of India of COVI-VAC, a single-dose, intranasal vaccine against the SARS-CoV-2 virus.
Will the speed of biotech innovation seen during the COVID-19 pandemic be maintained going forward, or will the market revert to the status quo? A panel of speakers discussed these questions during a January 7 advance session of the Biotech Showcase, a virtual event to be held January 11-15. Discuss
The U.K.'s Medicines and Healthcare products Regulatory Agency approved Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273, for use under Regulation 174.
CureVac and Bayer have signed a collaboration and services agreement to develop a new class of medicines based on messenger RNA, starting with CureVac's COVID-19 vaccine candidate, CVnCoV.
MilliporeSigma has purchased messenger RNA firm AmpTec. The deal is expected to boost MilliporeSigma's ability to develop and manufacture messenger RNA for use in COVID-19 vaccines and treatments.
The European Commission (EC) has granted a conditional marketing authorization for Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273. The authorization allows vaccination programs using the Moderna vaccine to be rolled out across the European Union.
The global COVID-19 pandemic has placed an urgent burden on governments to serve society, and with the help of the biotechnology and pharmaceutical industries, the job is getting done. That's according to Moncef Slaoui, PhD, chief adviser of the U.S. government's Operation Warp Speed project, who discussed his unique experiences at an advance session of the Biotech Showcase virtual event on January 5. Discuss
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
